ABSTRACT
Background Despite the well-known impact of delirium on long-term clinical outcomes, identification of delirium in electronic health records (EHR) remains difficult due to inadequate assessment or documentation of delirium. The purpose of this research is to present a classification model that identifies delirium using retrospective EHR data. The classification model would support the additional identification of delirium cases otherwise undocumented during routine practice.
Methods Delirium was confirmed with the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Age, sex, Elixhauser comorbidity index, drug exposures, and diagnoses were used as features to train the logistic regression and multi-layer perceptron models. The clinical notes from the EHR were parsed to supplement the features that were not recorded in the structured data. The model performance was evaluated with a 5-fold cross-validation area under the receiver operating characteristic curve (AUC).
Results Seventy-six patients (17 cases and 59 controls) with at least one CAM-ICU evaluation result during ICU stay from January 30, 2018 to February 20, 2018 were included in the model. The multi-layer perceptron model achieved the best performance in identifying delirium; mean AUC of 0.967 ± 0.019. The mean positive predictive value (PPV), mean negative predicted value (NPV), mean sensitivity, and mean specificity of the MLP model were 0.9, 0.88, 0.56, and 0.95, respectively.
Conclusion A simple classification model showed a mean AUC over 0.95. This model promises to identify delirium cases with EHR data, thereby enable a sustainable infrastructure to build a retrospective cohort of delirium in the ICU. The cohort would be useful for the evaluation of long-term sequelae of delirium in ICU.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was sponsored by National Library of Medicine grant 5R01LM009886-11 and National Center for Advancing Clinical and Translational Science grants UL1TR001873 and 1OT2TR003434-01.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by Columbia University Irving Medical Center (CUIMC) institutional review board and informed consent was waived.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available due to patient privacy.
